AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

BRIMONIDINE

10 registrations across 4 African markets— 3 active

Markets with BRIMONIDINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
BRIMONIDINE BIOGARAN 2MG/ML COLLYRE EN SOLUTION FLACON DE 1🇨🇮Côte d'IvoireBIOGARANactiveApr 2028
BRIMOL COLLYRE FLACON DE 5ML🇨🇮Côte d'IvoireSOFARMEDexpiredOct 2024
HANUDINE 0,2% COLLYRE FLACON DE 10ML🇨🇮Côte d'IvoireHANUCHEMexpiredFeb 2024
ALPHAGAN
Collyre / 2mg/ml
🇹🇳TunisiaABBVIE LIMITED.expiredJun 2023
BRIMOCHEK 0,2% COLLYRE FLACON DE 5ML🇨🇮Côte d'IvoireINDOCO REMEDIES LIMITEDexpiredJan 2023
ALPHACOL FREE
Collyre / 0.2%
🇹🇳TunisiaUNIMEDexpiredFeb 2015
ALPHACOL
Collyre / 0.2%
🇹🇳TunisiaUNIMEDexpiredAug 2014
ALPHACOL
Collyre / 0.2%
🇹🇳TunisiaUNIMEDexpiredAug 2014
BRIMO
collyre / 0,2 %
🇸🇳SenegalJAMJOOM PHARMAactive
ALPHAGAN
COLLYRE
🇲🇦Moroccoactive

BRIMONIDINE in Africa — Regulatory Overview

BRIMONIDINE is registered across 4 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Côte d'Ivoire, Tunisia, Morocco, Senegal. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 3 (30%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.